We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bisphosphonates and lower mortality risk: when it sounds to be good to be true ...
- Authors
Leslie, W. D.
- Abstract
The author discusses several studies on bisphosphonates and lower mortality risk. Topics covered include an increase in evidence of shared risk factors between osteoporosis and atherosclerosis, side benefit for treatment with intravenous zoledronic acid after a hip fracture, and mortality in hip fracture patients identified through the Swedish Hip Fracture register.
- Subjects
DIPHOSPHONATES; MORTALITY prevention; MORTALITY risk factors; COMBINATION drug therapy; CAUSES of death; BONE fractures; HIP joint injuries; ORAL drug administration; OSTEOPOROSIS; SERIAL publications; BONE density; TREATMENT effectiveness; ALENDRONATE; ZOLEDRONIC acid; RISEDRONATE; DISEASE risk factors
- Publication
Osteoporosis International, 2019, Vol 30, Issue 12, p2365
- ISSN
0937-941X
- Publication type
Editorial
- DOI
10.1007/s00198-019-05157-6